Search Results Search Sort by RelevanceMost Recent State of the Art and Science Feb 2017 Reasonableness, Credibility, and Clinical Disagreement Mary Jean Walker, PhD and Wendy A. Rogers, BMBS, PhD When is a source credible and how do beliefs about a source’s credibility influence assessments of evidence? AMA J Ethics. 2017;19(2):176-182. doi: 10.1001/journalofethics.2017.19.2.stas1-1702. State of the Art and Science Jun 2023 Patient-Reported Outcome Measures in Gender-Affirming Surgery Manraj Kaur, PhD, MSc, Shane Morrison, MD, MS, Andrea Pusic, MD, MHS, and Anne Klassen, DPhil PROM data can contribute to evidence-based, shared decision making and just access to gender-affirming surgical care. AMA J Ethics. 2023;25(6):E421-430. doi: 10.1001/amajethics.2023.421. State of the Art and Science Apr 2005 Complications of Anticoagulation with Heparin Mahesh Krishnamurthy, MD and Michael L. Freedman, MD Virtual Mentor. 2005;7(4):297-300. doi: 10.1001/virtualmentor.2005.7.4.cprl1-0504. State of the Art and Science Jun 2005 Recognition and Treatment of Depression Holly A. Swartz, MD Virtual Mentor. 2005;7(6):430-434. doi: 10.1001/virtualmentor.2005.7.6.cprl1-0506. State of the Art and Science Jul 2005 Evaluation of the Solitary Pulmonary Nodule Julia Feliz Alvarado, MD and Richard Albert, MD Virtual Mentor. 2005;7(7):485-488. doi: 10.1001/virtualmentor.2005.7.7.cprl1-0507. State of the Art and Science Sep 2005 Approach to the Patient with Alcoholic Liver Disease Howard J. Worman, MD Virtual Mentor. 2005;7(9):600-603. doi: 10.1001/virtualmentor.2005.7.9.cprl1-0509. State of the Art and Science Sep 2017 Why It’s Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy Sarah E. Wakeman, MD Although effective, opioid agonist therapy is associated with stigma and thus underutilized for treatment of opioid use disorder in incarcerated settings. AMA J Ethics. 2017;19(9):922-930. doi: 10.1001/journalofethics.2017.19.9.stas1-1709. State of the Art and Science Dec 2004 The Impact of Recent Clinical Trials on National Cholesterol Education Program Adult Treatment Panel III Guidelines Niharika P. Bansal Virtual Mentor. 2004;6(12):550-553. doi: 10.1001/virtualmentor.2004.6.12.cprl1-0412. State of the Art and Science Jan 2003 How to Change Routes of Administration of Opioids Audiey Kao, MD, PhD Virtual Mentor. 2003;5(1):19-20. doi: 10.1001/virtualmentor.2003.5.1.cprl1-0301. State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page Next › Last page Last »
State of the Art and Science Feb 2017 Reasonableness, Credibility, and Clinical Disagreement Mary Jean Walker, PhD and Wendy A. Rogers, BMBS, PhD When is a source credible and how do beliefs about a source’s credibility influence assessments of evidence? AMA J Ethics. 2017;19(2):176-182. doi: 10.1001/journalofethics.2017.19.2.stas1-1702.
State of the Art and Science Jun 2023 Patient-Reported Outcome Measures in Gender-Affirming Surgery Manraj Kaur, PhD, MSc, Shane Morrison, MD, MS, Andrea Pusic, MD, MHS, and Anne Klassen, DPhil PROM data can contribute to evidence-based, shared decision making and just access to gender-affirming surgical care. AMA J Ethics. 2023;25(6):E421-430. doi: 10.1001/amajethics.2023.421.
State of the Art and Science Apr 2005 Complications of Anticoagulation with Heparin Mahesh Krishnamurthy, MD and Michael L. Freedman, MD Virtual Mentor. 2005;7(4):297-300. doi: 10.1001/virtualmentor.2005.7.4.cprl1-0504.
State of the Art and Science Jun 2005 Recognition and Treatment of Depression Holly A. Swartz, MD Virtual Mentor. 2005;7(6):430-434. doi: 10.1001/virtualmentor.2005.7.6.cprl1-0506.
State of the Art and Science Jul 2005 Evaluation of the Solitary Pulmonary Nodule Julia Feliz Alvarado, MD and Richard Albert, MD Virtual Mentor. 2005;7(7):485-488. doi: 10.1001/virtualmentor.2005.7.7.cprl1-0507.
State of the Art and Science Sep 2005 Approach to the Patient with Alcoholic Liver Disease Howard J. Worman, MD Virtual Mentor. 2005;7(9):600-603. doi: 10.1001/virtualmentor.2005.7.9.cprl1-0509.
State of the Art and Science Sep 2017 Why It’s Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy Sarah E. Wakeman, MD Although effective, opioid agonist therapy is associated with stigma and thus underutilized for treatment of opioid use disorder in incarcerated settings. AMA J Ethics. 2017;19(9):922-930. doi: 10.1001/journalofethics.2017.19.9.stas1-1709.
State of the Art and Science Dec 2004 The Impact of Recent Clinical Trials on National Cholesterol Education Program Adult Treatment Panel III Guidelines Niharika P. Bansal Virtual Mentor. 2004;6(12):550-553. doi: 10.1001/virtualmentor.2004.6.12.cprl1-0412.
State of the Art and Science Jan 2003 How to Change Routes of Administration of Opioids Audiey Kao, MD, PhD Virtual Mentor. 2003;5(1):19-20. doi: 10.1001/virtualmentor.2003.5.1.cprl1-0301.
State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411.